Superbore Aspiration Catheters: An Innovation in Mechanical Thrombectomy
- 1Department of Neurology, University of Texas Rio Grande Valley, Edinburg.
Abstract
Mechanical thrombectomy has become the standard treatment for acute ischemic stroke caused by large vessel occlusion. Aspiration thrombectomy has evolved substantially over the past decade; however, conventional large-bore aspiration catheters (inner diameter ≥0.068″) may be limited by incomplete clot ingestion, distal embolization, and dependence on adjunctive devices such as balloon guide catheters to achieve proximal flow arrest. Superbore aspiration catheters, typically defined by an inner diameter ≥0.080 inches, are the most recent technological advancement in aspiration thrombectomy. Superbore catheters have the ability to navigate to the M1 segment of the middle cerebral artery, facilitating local flow control, complete clot ingestion, and distal flow reversal during aspiration. Since 2020, several superbore systems have been developed, including Zoom 88 (Imperative Care), HiPoint 88 (Route 92 Medical), Millipede88 (Perfuze), SOFIA 88 (Terumo), Broadway 8 (Stryker Neurovascular), and Cereglide 92 (Johnson & Johnson MedTech). Early clinical studies suggest that superbore catheters may improve first-pass effect and final reperfusion rates compared with standard aspiration thrombectomy devices, while maintaining an acceptable safety profile. This review summarizes the design characteristics, clinical evidence, and procedural considerations associated with currently available superbore systems. Although preliminary data are promising, further randomized clinical trials are needed to determine the optimal role of superbore aspiration in large vessel occlusion treatment.
Related
- Passive Advancement of the Aspiration Catheter During Mechanical Thrombectomy is Independently Associated with Superior Recanalization Outcomes
- Clot Out, Flow Back: Large-Bore Aspiration Thrombectomy for Symptomatic Early Transjugular Intrahepatic Portosystemic Shunt (TIPS) Occlusion.
- Aspiration Thrombectomy for High-Risk Pulmonary Embolism With Life-Threatening Anemia and Active Uterine Bleeding: A Case Report.
- Outcomes Following First-Pass Direct Aspiration Versus Stent Retriever for Endovascular Thrombectomy in Primary Medium or Distal Vessel Occlusion: An Analysis of the SVIN Registry
- Mechanical thrombectomy for superior sagittal sinus thrombosis in early pregnancy: a case report
BibTeX
@article{callan2026superbore,
title = {{Superbore Aspiration Catheters: An Innovation in Mechanical Thrombectomy}},
author = {Andrew B Callan and Ameer E Hassan},
journal = {Stroke (Hoboken, N.J.)},
year = {2026},
month = oct,
doi = {10.1161/svin.126.002492},
url = {https://europepmc.org/article/PMC/PMC13727193},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Superbore Aspiration Catheters: An Innovation in Mechanical Thrombectomy
AU - Andrew B Callan
AU - Ameer E Hassan
PY - 2026
DA - 2026/10/02
JO - Stroke (Hoboken, N.J.)
DO - 10.1161/svin.126.002492
UR - https://europepmc.org/article/PMC/PMC13727193
AB - Mechanical thrombectomy has become the standard treatment for acute ischemic stroke caused by large vessel occlusion. Aspiration thrombectomy has evolved substantially over the past decade; however, conventional large-bore aspiration catheters (inner diameter ≥0.068″) may be limited by incomplete clot ingestion, distal embolization, and dependence on adjunctive devices such as balloon guide catheters to achieve proximal flow arrest. Superbore aspiration catheters, typically defined by an inner diameter ≥0.080 inches, are the most recent technological advancement in aspiration thrombectomy. Superbore catheters have the ability to navigate to the M1 segment of the middle cerebral artery, facilitating local flow control, complete clot ingestion, and distal flow reversal during aspiration. Since 2020, several superbore systems have been developed, including Zoom 88 (Imperative Care), HiPoint 88 (Route 92 Medical), Millipede88 (Perfuze), SOFIA 88 (Terumo), Broadway 8 (Stryker Neurovascular), and Cereglide 92 (Johnson & Johnson MedTech). Early clinical studies suggest that superbore catheters may improve first-pass effect and final reperfusion rates compared with standard aspiration thrombectomy devices, while maintaining an acceptable safety profile. This review summarizes the design characteristics, clinical evidence, and procedural considerations associated with currently available superbore systems. Although preliminary data are promising, further randomized clinical trials are needed to determine the optimal role of superbore aspiration in large vessel occlusion treatment.
SN - 2694-5746
ER -